Answers are grounded in this paper and cite their sources.
Background: Tuberculosis (TB) is a severe infectious disease that involves the lungs as well as other systems of the body.Immunity in TB is dependent on interaction between pro-and anti-inflammatory cytokines, leading to the development of an effective anti-mycobacterial response.Interleukin-6 (IL-6) has a proven role in the pathogenesis of TB.Vitamin D mediates the expression of genes required for the production of cytokines that elevate immune response against Mycobacterium tuberculosis (M.TB).Hence, a study was conducted to evaluate the role of vitamin D supplementation on sputum smear conversion rates and IL-6 levels in pulmonary tuberculosis (PTB) patients.Methods: A randomized controlled trial was conducted in a tertiary care institute from December 2020 to May 2022, in which 50 freshly confirmed cases of PTB were enrolled.Baseline levels of IL-6 were estimated, and sputum smear microscopy was done in all patients.Randomization of patients was done into two groups, A and B, with an intervention arm and a control arm, respectively.In group A, patients received a vitamin D oral dose of 60,000 IU once a week for eight weeks starting from week 0, in addition to anti-TB treatment, whereas group B patients received anti-TB treatment and a placebo.After 8 weeks of treatment, sputum microscopy for acid-fast bacilli (AFB) and estimation of IL-6 levels were done, and the results were compared.Results: Interleukin-6 levels before initiating the treatment were comparable between the two groups A and B (p = 0.669).There was a decrease in the IL-6 levels in both study arms at the end of 8 weeks.However, the change was not statistically significant in intergroup analysis (p-value 0.22).Sputum smear AFB grading was comparable between both study arms at the baseline (p = 0.196).Sputum smear conversion rate was 88% in the intervention arm (group A), whereas it was 72% in the control arm (group B).However, on intergroup analysis was not found to be statistically significant (p = 0.289).Conclusion: This study showed no significant change in sputum conversion rates and serum IL-6 levels after vitamin D supplementation for 8 weeks.However, a larger clinical trial may be required to explore the role of vitamin D and its association with IL-6 levels in patients of PTB.
No takes yet. Share an insight, caveat, or question.
Aulakh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: